Suppr超能文献

食管胃交界部流出道梗阻的诊断与管理

Diagnosis and Management of Esophagogastric Junction Outflow Obstruction.

作者信息

Beveridge Claire, Lynch Kristle

机构信息

Dr Beveridge is a fellow and Dr Lynch is an assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology at the University of Pennsylvania in Philadelphia, Pennsylvania.

出版信息

Gastroenterol Hepatol (N Y). 2020 Mar;16(3):131-138.

Abstract

Esophagogastric junction outflow obstruction (EGJOO) is an abnormal topographic pattern seen on high-resolution manometry. EGJOO is characterized by an elevated median integrated relaxation pressure with intact or weak peristalsis, thus not meeting the criteria for achalasia. This diagnosis has a female predominance and is associated with varying presenting symptoms. EGJOO can be idiopathic or secondary. It is important to assess for secondary causes, including structural or medication-related ones. Cross-sectional imaging is recommended to rule out secondary causes; however, increasing evidence suggests that esophagogastroduodenoscopy and barium esophagram are usually sufficient. The disease course is variable, with up to three-quarters of patients experiencing spontaneous resolution of symptoms over 6 months. In patients who have mild symptoms, it is reasonable to observe and consider treatment if symptoms persist. Variable response has been seen in small studies with both medical treatment and botulinum toxin injection of the lower esophageal sphincter. For patients with significant symptoms and objective evidence of obstruction on imaging, targeted therapy of the lower esophageal sphincter should be considered via pneumatic dilation or myotomy.

摘要

食管胃交界部流出道梗阻(EGJOO)是在高分辨率测压中观察到的一种异常形态模式。EGJOO的特征是中位综合松弛压升高,蠕动完整或减弱,因此不符合贲门失弛缓症的标准。这种诊断以女性居多,并伴有不同的临床表现。EGJOO可为特发性或继发性。评估继发性病因很重要,包括结构性或药物相关病因。建议进行横断面成像以排除继发性病因;然而,越来越多的证据表明,食管胃十二指肠镜检查和钡剂食管造影通常就足够了。病程多变,多达四分之三的患者在6个月内症状会自发缓解。对于症状较轻的患者,观察并在症状持续时考虑治疗是合理的。在关于药物治疗和食管下括约肌肉毒杆菌毒素注射的小型研究中,已观察到不同的反应。对于有明显症状且影像学检查有梗阻客观证据的患者,应考虑通过气囊扩张或肌切开术对食管下括约肌进行靶向治疗。

相似文献

1
Diagnosis and Management of Esophagogastric Junction Outflow Obstruction.
Gastroenterol Hepatol (N Y). 2020 Mar;16(3):131-138.
3
Management of the patient with esophagogastric junction outflow obstruction.
Curr Opin Gastroenterol. 2021 Jul 1;37(4):397-407. doi: 10.1097/MOG.0000000000000747.
4
Esophagogastric Junction Outflow Obstruction (EGJOO): A Manometric Phenomenon or Clinically Impactful Problem.
Curr Gastroenterol Rep. 2024 Jul;26(7):173-180. doi: 10.1007/s11894-024-00928-6. Epub 2024 Mar 28.
5
Esophagogastric junction outflow obstruction: Where are we now in diagnosis and management?
World J Gastroenterol. 2019 Jan 28;25(4):411-417. doi: 10.3748/wjg.v25.i4.411.
6
Updated Systematic Review of Achalasia, with a Focus on POEM Therapy.
Dig Dis Sci. 2020 Jan;65(1):38-65. doi: 10.1007/s10620-019-05784-3. Epub 2019 Aug 27.
7
Low Yield of Cross-Sectional Imaging in Patients With Esophagogastric Junction Outflow Obstruction.
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1643-1644. doi: 10.1016/j.cgh.2019.07.044. Epub 2019 Jul 27.
9
Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry.
Neurogastroenterol Motil. 2016 Jan;28(1):116-26. doi: 10.1111/nmo.12708. Epub 2015 Oct 30.
10
Esophagogastric Junction Outflow Obstruction: A Diagnosis in Evolution.
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):108-114.

引用本文的文献

3
Diagnostic approach to patients with suspected motility disorders: one size does not fit all.
Ann Gastroenterol. 2025 Jan-Feb;38(1):12-19. doi: 10.20524/aog.2025.0941. Epub 2024 Dec 23.
4
Look above the IRP: predicting abnormal confirmatory testing in patients with esophagogastric junction outflow obstruction.
Therap Adv Gastroenterol. 2024 Dec 23;17:17562848241306128. doi: 10.1177/17562848241306128. eCollection 2024.
6
Esophageal Per-Oral Endoscopic Myotomy (E-POEM): Future Directions and Perspectives.
Curr Gastroenterol Rep. 2024 Oct;26(10):241-250. doi: 10.1007/s11894-024-00938-4. Epub 2024 Aug 8.
7
Esophagogastric Junction Outflow Obstruction (EGJOO): A Manometric Phenomenon or Clinically Impactful Problem.
Curr Gastroenterol Rep. 2024 Jul;26(7):173-180. doi: 10.1007/s11894-024-00928-6. Epub 2024 Mar 28.
8
Artificial Intelligence Tools for Improving Manometric Diagnosis of Esophageal Dysmotility.
Curr Gastroenterol Rep. 2024 Apr;26(4):115-123. doi: 10.1007/s11894-024-00921-z. Epub 2024 Feb 7.
10
Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients.
ERJ Open Res. 2023 Sep 10;9(5). doi: 10.1183/23120541.00222-2023. eCollection 2023 Sep.

本文引用的文献

2
Esophagogastric junction outflow obstruction on manometry: Outcomes and lack of benefit from CT and EUS.
Neurogastroenterol Motil. 2019 Dec;31(12):e13712. doi: 10.1111/nmo.13712. Epub 2019 Sep 15.
3
Low Yield of Cross-Sectional Imaging in Patients With Esophagogastric Junction Outflow Obstruction.
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1643-1644. doi: 10.1016/j.cgh.2019.07.044. Epub 2019 Jul 27.
4
Pharmacologic interrogation of patients with esophagogastric junction outflow obstruction using amyl nitrite.
Neurogastroenterol Motil. 2019 Sep;31(9):e13668. doi: 10.1111/nmo.13668. Epub 2019 Jun 25.
5
Diagnosis and Management of Esophagogastric Junction Outflow Obstruction.
Am J Gastroenterol. 2019 Apr;114(4):544-547. doi: 10.14309/ajg.0000000000000100.
7
Impact of Peppermint Therapy on Dysphagia and Non-cardiac Chest Pain: A Pilot Study.
Dig Dis Sci. 2019 Aug;64(8):2214-2218. doi: 10.1007/s10620-019-05523-8. Epub 2019 Feb 15.
9
Upright Integrated Relaxation Pressure Facilitates Characterization of Esophagogastric Junction Outflow Obstruction.
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2218-2226.e2. doi: 10.1016/j.cgh.2019.01.024. Epub 2019 Jan 29.
10
Esophagogastric junction outflow obstruction: Where are we now in diagnosis and management?
World J Gastroenterol. 2019 Jan 28;25(4):411-417. doi: 10.3748/wjg.v25.i4.411.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验